The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock List
ChartZero.com
ChartZero

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Wed., Mar. 4, 7:12 PM

Slide #16. Catalent Secondary Offering

Company: Catalent (NYSE:CTLT)
Date announced: 3/2/2015
Shares Offered: 23,700,000
Date of Pricing: 3/3/2015
Price Per Share: $29.50
Secondary Offering Details: Catalent, Inc. ("Catalent") (NYSE:CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced the launch of a secondary public offering of its common stock. Certain stockholders of Catalent (the "Selling Stockholders") are offering for sale to the public 20 million shares of Catalent's common stock owned by them. The Selling Stockholders will grant to the underwriters of the secondary offering an option to purchase up to 3 million additional shares of common stock. Catalent is not offering any stock in this transaction and will not receive any proceeds from the sale of the shares by the Selling Stockholders. - updated 3/4 - Catalent, Inc. ("Catalent") (NYSE:CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced the pricing of an upsized secondary public offering of 23.7 million shares of its common stock by certain of its stockholders (the "Selling Stockholders") at a price to the public of $29.50 per share. In addition, the Selling Stockholders have granted the underwriters a 30-day over-allotment option to purchase up to an additional 3.555 million shares of common stock. The offering is expected to close on March 9, 2015, subject to customary closing conditions. Catalent is not selling any stock in this transaction and will not receive any proceeds from the sale of the shares by the Selling Stockholders.

Catalent is a provider of enhanced delivery technologies and development solutions for drugs, biologics and consumer health products. Co.'s segments include: Oral Technologies, which formulates, develops and manufactures prescription and consumer health products; Medication Delivery Solutions, which formulates, develops and manufactures prefilled syringes and other injectable formats; blow-fill-seal unit dose development and manufacturing as well as biologic cell line development and manufacturing; and Development and Clinical Services, which among others manufactures, packaging, storage, distribution and inventory management for global clinical trials of drugs and biologics.
Open the CTLT Page at The Online Investor »

Company Name:  Catalent Inc
Website:  www.catalent.com
Sector:  Drugs & Pharmaceuticals
Number of ETFs Holding CTLT:  18
Total Market Value Held by ETFs:  $83.19M
Total Market Capitalization:  $3.52B
% of Market Cap. Held by ETFs:  2.36%
 

Open the CTLT Page at The Online Investor (in a new window) »

March 4, 2015    7:12 PM Eastern
Quotes delayed 20 minutes



Strong Buy (3.56 out of 4)
74th percentile
(ranked higher than approx. 74% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Secondary Stock Offerings | www.TheOnlineInvestor.com | Copyright © 1998 - 2015, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.